Two Schemes Response in Multiple Myeloma
NCT06284395
·
clinicaltrials.gov ↗
RECRUITING
Status
83
Enrollment
OTHER_GOV
Sponsor class
Conditions
Response, Acute Phase
Survivorship
Interventions
DRUG:
Bortezomib
Sponsor
Hospital General de Mexico